Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upArticles
Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing
April 24, 2026
Intellectual Asset Management (IAM)Articles
Trending at the PTAB: The Policies That Are Redefining IPR Trending at the PTAB: The Policies That Are Redefining IPR
January 6, 2026
Law360Articles
Trending at the PTAB: The Journey of IPR Institution in 2025 Trending at the PTAB: The Journey of IPR Institution in 2025
January 5, 2026
Law360Articles
Trending at the PTAB: 6 Areas to Watch in 2024 Trending at the PTAB: 6 Areas to Watch in 2024
January 2, 2024
Law360Articles
How the PTAB Landscape Shifted in 2023 How the PTAB Landscape Shifted in 2023
December 15, 2023
Law360Articles
Negotiating AI-Life Sciences Partnerships to Minimize IP Risk Negotiating AI-Life Sciences Partnerships to Minimize IP Risk
August 4, 2023
Law360Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology Patent Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology Patent Law
April 27, 2023
Cambridge
Articles
Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences
January 2023
International Pharmaceutical IndustryWebinar
U.S. Medical Device Patent Strategies and Patent Eligibility U.S. Medical Device Patent Strategies and Patent Eligibility
September 17, 2020
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.